The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 801–1,000 of 3,517
Karishma, K. K., & Herbert, J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02099.x · Cited by 297
Physiological and pathophysiological roles of nitric oxide in the central nervous system
Szabó, C. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(96)00159-1 · Cited by 297
Gelenberg, A. J., Lydiard, R. B., Rudolph, R. L., Aguiar, L., Haskins, J. T., & Salinas, E. (2000) · JAMA · doi:10.1001/jama.283.23.3082 · Cited by 296
Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists
Gray, J. A., & Roth, B. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00623-2 · Cited by 296
The formation of Uranus and Neptune in the Jupiter–Saturn region of the Solar System
Thommes, E. W., Duncan, M. J., & Levison, H. F. (1999) · Nature · doi:10.1038/45185 · Cited by 295
The Metabotropic Glutamate Receptors: Structure, Activation Mechanism and Pharmacology
Pin, J.-P., & Acher, F. (2002) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007023339328 · Cited by 294
Sur, C., Mallorga, P. J., Wittmann, M., Jacobson, M. A., Pascarella, D., Williams, J. B., Brandish, P. E., Pettibone, D. J., Scolnick, E. M., & Conn, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835612100 · Cited by 294
Therapeutic use of sleep deprivation in depression
Giedke, H., & Schwärzler, F. (2002) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(02)90235-2 · Cited by 294
??-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders
Hayashi, T., & Su, T.-P. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00001 · Cited by 294
Nelson, J. C. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280019002 · Cited by 294
Biodiversity, Distributions and Adaptations of Arctic Species in the Context of Environmental Change
Callaghan, T. V., Björn, L. O., Chernov, Y., Chapin, T., Christensen, T. R., Huntley, B., Ims, R. A., Johansson, M., Jolly, D., Jonasson, S., et al. (2004) · AMBIO: A Journal of the Human Environment · doi:10.1579/0044-7447-33.7.404 · Cited by 294
Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile
Schmidt, A. W., Lebel, L. A., Howard, H. R., & Zorn, S. H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01188-8 · Cited by 293
Antidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2C Receptors
Cryan, J. F., & Lucki, I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39013-5 · Cited by 293
Müller, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00099-3 · Cited by 292
m-Chlorophenylpiperazine as a probe of serotonin function
Kahn, R. S., & Wetzler, S. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90184-n · Cited by 292
VALENTINO, R. J., FOOTE, S. L., & PAGE, M. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb49931.x · Cited by 292
Inhibition of P-Glycoprotein by Newer Antidepressants
Weiss, J., Dormann, S.-M. G., Martin-Facklam, M., Kerpen, C. J., Ketabi-Kiyanvash, N., & Haefeli, W. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046532 · Cited by 292
Jiménez, F., Velasco, F., Salin-Pascual, R., Hernández, J. A., Velasco, M., Criales, J. L., & Nicolini, H. (2005) · Neurosurgery · doi:10.1227/01.neu.0000170434.44335.19 · Cited by 291
Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice
Vickers, S. P., Clifton, P. G., Dourish, C. T., & Tecott, L. H. (1999) · Psychopharmacology · doi:10.1007/s002130050952 · Cited by 291
Iyengar, S., Webster, A. A., Hemrick-Luecke, S. K., Xu, J. Y., & Simmons, R. M. A. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070656 · Cited by 291
Lauterborn, J. C., Lynch, G., Vanderklish, P., Arai, A., & Gall, C. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00008.2000 · Cited by 290
Barch, D. M., Sheline, Y. I., Csernansky, J. G., & Snyder, A. Z. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01674-8 · Cited by 290
Martin‐Schild, S., Gerall, A. A., Kastin, A. J., & Zadina, J. E. (1999) · Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990322)405:4<450::aid-cne2>3.0.co;2-# · Cited by 290
Behavioral characterization of neuropeptide Y knockout mice
Bannon, A. W., Seda, J., Carmouche, M., Francis, J. M., Norman, M. H., Karbon, B., & McCaleb, M. L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02285-x · Cited by 290
Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes
Marangell, L. B., Rush, A. J., George, M. S., Sackeim, H. A., Johnson, C. R., Husain, M. M., Nahas, Z., & Lisanby, S. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01343-9 · Cited by 290
FIXED‐INTERVAL SCHEDULE OF COCAINE REINFORCEMENT: EFFECT OF DOSE AND INFUSION DURATION1
Balster, R. L., & Schuster, C. R. (1973) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1973.20-119 · Cited by 290
Naritoku, D. K., Terry, W. J., & Helfert, R. H. (1995) · Epilepsy Research · doi:10.1016/0920-1211(95)00035-9 · Cited by 290
The benzodiazepine binding site of GABAA receptors
Sigel, E., & Buhr, A. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90675-1 · Cited by 290
The role of dopamine in the mechanism of action of antidepressant drugs
D'Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00566-5 · Cited by 289
The many faces of fatigue in major depressive disorder
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004729 · Cited by 288
Broughton, R. J., Fleming, J. A. E., George, C. F. P., Hill, J. D., Kryger, M. H., Moldofsky, H., Montplaisir, J. Y., Morehouse, R. L., Moscovitch, A., & Murphy, W. F. (1997) · Neurology · doi:10.1212/wnl.49.2.444 · Cited by 288
A Genome-Wide Survey of Human Pseudogenes
Torrents, D. (2003) · Genome Research · doi:10.1101/gr.1455503 · Cited by 288
Moore, R. Y., & Card, J. P. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903440306 · Cited by 287
Opiate reward: Sites and substrates
Wise, R. A. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80021-1 · Cited by 287
A renaissance in trace amines inspired by a novel GPCR family
Lindemann, L., & Hoener, M. C. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.007 · Cited by 287
Serotonin and the regulation of mammalian circadian rhythmicity
Morin, L. P. (1999) · Annals of Medicine · doi:10.3109/07853899909019259 · Cited by 286
Animal Models of Depression: Utility for Transgenic Research
Porsolt, R. D. (2000) · Reviews in the Neurosciences · doi:10.1515/revneuro.2000.11.1.53 · Cited by 285
Marshall, D. L., Redfern, P. H., & Wonnacott, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041511.x · Cited by 284
Drugs as materials: valuing physical form in drug discovery
Gardner, C. R., Walsh, C. T., & Almarsson, Ö. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1550 · Cited by 284
Fryer, J. D., & Lukas, R. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37928-5 · Cited by 283
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 283
Self-citationLocalization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain
Herzog, E., Gilchrist, J., Gras, C., Muzerelle, A., Ravassard, P., Giros, B., Gaspar, P., & El Mestikawy, S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.039 · Cited by 283
Pharmacogenetics of Antidepressant Medication Intolerance
Murphy, G. M., Kremer, C., Rodrigues, H. E., & Schatzberg, A. F. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1830 · Cited by 283
Wu, Y.-H., Feenstra, M. G. P., Zhou, J.-N., Liu, R.-Y., Toranõ, J. S., Van Kan, H. J. M., Fischer, D. F., Ravid, R., & Swaab, D. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030833 · Cited by 283
Rapid Reversal of Psychotic Depression Using Mifepristone
Belanoff, J. K., Flores, B. H., Kalezhan, M., Sund, B., & Schatzberg, A. F. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00009 · Cited by 282
Basic Mechanisms of Sleep-Wake States
Jones, B. E. (2005) · Principles and Practice of Sleep Medicine · doi:10.1016/b0-72-160797-7/50018-5 · Cited by 282
Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.002 · Cited by 282
Gene–environment interaction and the genetics of depression
Lesch, K. P. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0420 · Cited by 282
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
Hedlund, P. B., Huitron-Resendiz, S., Henriksen, S. J., & Sutcliffe, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.012 · Cited by 281
The coming Kuhnian revolution in biology
Strohman, R. C. (1997) · Nature Biotechnology · doi:10.1038/nbt0397-194 · Cited by 281
Nicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279
Hoffman, B. J., Hansson, S. R., Mezey, É., & Palkovits, M. (1998) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0168 · Cited by 279
Prefrontal Cortical Dysfunction in Depression Determined by Wisconsin Card Sorting Test Performance
Merriam, E. P., Thase, M. E., Haas, G. L., Keshavan, M. S., & Sweeney, J. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.780 · Cited by 278
Oligomerization and Trafficking of the Human Dopamine Transporter
Torres, G. E., Carneiro, A., Seamans, K., Fiorentini, C., Sweeney, A., Yao, W.-D., & Caron, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m201926200 · Cited by 278
Lindemann, L., Ebeling, M., Kratochwil, N. A., Bunzow, J. R., Grandy, D. K., & Hoener, M. C. (2005) · Genomics · doi:10.1016/j.ygeno.2004.11.010 · Cited by 278
Hayer‐Zillgen, M., Brüss, M., & Bönisch, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704785 · Cited by 278
Attentional functions of cortical cholinergic inputs: What does it mean for learning and memory?
Sarter, M., Bruno, J. P., & Givens, B. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00070-4 · Cited by 278
Kreiss, D. S., & Lucki, I. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10650-2 · Cited by 277
Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists
Rupniak, N. M. J., & Kramer, M. S. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01396-6 · Cited by 276
Kaidanovich-Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276
Scalable architecture in mammalian brains
Clark, D. A., Mitra, P. P., & Wang, S. S.-H. (2001) · Nature · doi:10.1038/35075564 · Cited by 276
Marek, G. J., Carpenter, L. L., McDougle, C. J., & Price, L. H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300057 · Cited by 275
Hernando, F. (2001) · Endocrinology · doi:10.1210/en.142.4.1659 · Cited by 275
Murphy, G. M., Hollander, S. B., Rodrigues, H. E., Kremer, C., & Schatzberg, A. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1163 · Cited by 275
Nebes, R. D., Pollock, B. G., Houck, P. R., Butters, M. A., Mulsant, B. H., Zmuda, M. D., & Reynolds, C. F. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00085-7 · Cited by 275
κ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons
Margolis, E. B., Hjelmstad, G. O., Bonci, A., & Fields, H. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-31-09981.2003 · Cited by 275
Local circuit regulation of paraventricular nucleus stress integration
Herman, J. P., Tasker, J. G., Ziegler, D. R., & Cullinan, W. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00681-5 · Cited by 274
Neumeister, A., Nugent, A. C., Waldeck, T., Geraci, M., Schwarz, M., Bonne, O., Bain, E. E., Luckenbaugh, D. A., Herscovitch, P., Charney, D. S., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.765 · Cited by 273
Cognitive dysfunction and dementia in Parkinson?s disease
Bosboom, J. L. W., Stoffers, D., & Wolters, E. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0168-1 · Cited by 273
What Characteristics of Primary Anxiety Disorders Predict Subsequent Major Depressive Disorder?
Bittner, A., Goodwin, R. D., Wittchen, H.-U., Beesdo, K., Höfler, M., & Lieb, R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0505 · Cited by 272
Krystal, J. H., Abi-Saab, W., Perry, E., D’Souza, D. C., Liu, N., Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1982-8 · Cited by 272
Adler, C. H., Caviness, J. N., Hentz, J. G., Lind, M., & Tiede, J. (2003) · Movement Disorders · doi:10.1002/mds.10390 · Cited by 272
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
Nebert, D. W. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.560401.x · Cited by 272
Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation
Schaaf, M. J. M., De Kloet, E. R., & Vreugdenhil, E. (2000) · Stress · doi:10.3109/10253890009001124 · Cited by 270
Jin, H., May, M., Tranebjærg, L., Kendall, E., Fontán, G., Jackson, J., Subramony, S. H., Arena, F., Lubs, H., Smith, S., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-177 · Cited by 270
Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function
Qanbar, R., & Bouvier, M. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00300-5 · Cited by 270
Computational analysis of functional connectivity between areas of primate cerebral cortex
Stephan, K. E., Hilgetag, C., Burns, G. A. P. C., O'Neill, M. A., Young, M. P., & Kotter, R. (2000) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0552 · Cited by 270
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., & Brooks, D. J. (1999) · Brain · doi:10.1093/brain/122.9.1637 · Cited by 270
Lower dopamine transporter binding potential in striatum during depression
Meyer, J. H., Krüger, S., Wilson, A. A., Christensen, B. K., Goulding, V. S., Schaffer, A., Minifie, C., Houle, S., Hussey, D., & Kennedy, S. H. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00052 · Cited by 269
Mishima, K., Tozawa, T., Satoh, K., Matsumoto, Y., Hishikawa, Y., & Okawa, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00510-6 · Cited by 269
Bunney, W. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00145-1 · Cited by 268
Melatonin rhythmicity: effect of age and Alzheimer's disease
Skene, D. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00198-5 · Cited by 268
Effect of Agomelatine in the Chronic Mild Stress Model of Depression in the Rat
Papp, M., Gruca, P., Boyer, P.-A., & Mocaër, E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300091 · Cited by 268
Duehmke, R. M., Hollingshead, J., & Cornblath, D. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003726.pub3 · Cited by 267
Identification and Characterization of a Novel Monoamine Transporter in the Human Brain
Engel, K., Zhou, M., & Wang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407913200 · Cited by 267
The Glutamatergic System and Alzheimer???s Disease: Therapeutic Implications
Butterfield, D. A., & Pocernich, C. B. (2003) · CNS Drugs · doi:10.2165/00023210-200317090-00004 · Cited by 267
Piazzi, L., Rampa, A., Bisi, A., Gobbi, S., Belluti, F., Cavalli, A., Bartolini, M., Andrisano, V., Valenti, P., & Recanatini, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0340602 · Cited by 266
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<11::aid-da4>3.0.co;2-i · Cited by 266
How the global structure of protein interaction networks evolves
Wagner, A. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2002.2269 · Cited by 266
Spooren, W. P. J. M., Vassout, A., Neijt, H. C., Kuhn, R., Gasparini, F., Roux, S., Porsolt, R. D., & Gentsch, C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39029-9 · Cited by 266
Cryan, J. F., Kelly, P. H., Neijt, H. C., Sansig, G., Flor, P. J., & Van Der Putten, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02667.x · Cited by 266
Sánchez, C., Bergqvist, P. B. F., Brennum, L. T., Gupta, S., Hogg, S., Larsen, A., & Wiborg, O. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1364-z · Cited by 265
Prognostic Value of Anxiety and Depression in Patients With Chronic Heart Failure
Jiang, W., Kuchibhatla, M., Cuffe, M. S., Christopher, E. J., Alexander, J. D., Clary, G. L., Blazing, M. A., Gaulden, L. H., Califf, R. M., Krishnan, R. R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148138.25157.f9 · Cited by 264
Adverse effects of cannabis on health: an update of the literature since 1996
Kalant, H. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.027 · Cited by 264
Depression and vascular disease: what is the relationship?
Thomas, A. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00349-x · Cited by 264
Fava, M., Judge, R., Hoog, S. L., Nilsson, M. E., & Koke, S. C. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1109 · Cited by 263
Wigger, A., Sánchez, M. M., Mathys, K. C., Ebner, K., Frank, E., Liu, D., Kresse, A., Neumann, I. D., Holsboer, F., Plotsky, P. M., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300290 · Cited by 263
Widerlöv, E., Lindström, L. H., Wahlestedt, C., & Ekman, R. (1988) · Journal of Psychiatric Research · doi:10.1016/0022-3956(88)90030-1 · Cited by 263
El Yacoubi, M., Bouali, S., Popa, D., Naudon, L., Leroux-Nicollet, I., Hamon, M., Costentin, J., Adrien, J., & Vaugeois, J.-M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1034823100 · Cited by 263
Brady, A. E., & Limbird, L. E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00239-x · Cited by 263
Size and burden of depressive disorders in Europe
Paykel, E. S., Brugha, T., & Fryers, T. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.008 · Cited by 263
Hayashi, T., & Su, T.-P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051284 · Cited by 262
Fox, G. B., Esbenshade, T. A., Pan, J. B., Radek, R. J., Krueger, K. M., Yao, B. B., Browman, K. E., Buckley, M. J., Ballard, M. E., Komater, V. A., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078402 · Cited by 262
Albeck, D. S., McKittrick, C. R., Blanchard, D. C., Blanchard, R. J., Nikulina, J., McEwen, B. S., & Sakai, R. R. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04895.1997 · Cited by 261
Meta-analysis of serotonin transporter polymorphisms and affective disorders
Lotrich, F. E., & Pollock, B. G. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200409000-00001 · Cited by 261
Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260
Makino, S., Hashimoto, K., & Gold, P. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00791-8 · Cited by 260
MICHAEL, N., ERFURTH, A., OHRMANN, P., AROLT, V., HEINDEL, W., & PFLEIDERER, B. (2003) · Psychological Medicine · doi:10.1017/s0033291703007931 · Cited by 260
Efferent connections of the lateral hypothalamic area of the rat: An autoradiographic investigation
Berk, M. L., & Finkelstein, J. A. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90009-0 · Cited by 260
Azam, L., Winzer‐Serhan, U. H., Chen, Y., & Leslie, F. M. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10138 · Cited by 260
Increased stress response and β–phenylethylamine in MAOB–deficient mice
Grimsby, J., Toth, M., Chen, K., Kumazawa, T., Klaidman, L., Adams, J. D., Karoum, F., Gal, J., & Shih, J. C. (1997) · Nature Genetics · doi:10.1038/ng1097-206 · Cited by 258
A review of the role of serotonin receptors in psychiatric disorders
Naughton, M., Mulrooney, J. B., & Leonard, B. E. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/1099-1077(200008)15:6<397::aid-hup212>3.0.co;2-l · Cited by 258
Tanoue, A., Ito, S., Honda, K., Oshikawa, S., Kitagawa, Y., Koshimizu, T., Mori, T., & Tsujimoto, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19656 · Cited by 258
Le Poul, E., Laaris, N., Doucet, E., Laporte, A.-M., Hamon, M., & Lanfumey, L. (1995) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00176767 · Cited by 257
Molecular pharmacology of the opioid receptors
Satoh, M., & Minami, M. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02011-x · Cited by 257
David, S. P., Murthy, N. V., Rabiner, E. A., Munafó, M. R., Johnstone, E. C., Jacob, R., Walton, R. T., & Grasby, P. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3769-04.2005 · Cited by 257
Roth, B., Hanizavareh, S. M., & Blum, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1683-8 · Cited by 257
Serotonin in Pain and Analgesia: Actions in the Periphery
Sommer, C. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:2:117 · Cited by 256
Kramer, M. S., Winokur, A., Kelsey, J., Preskorn, S. H., Rothschild, A. J., Snavely, D., Ghosh, K., Ball, W. A., Reines, S. A., Munjack, D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300260 · Cited by 256
Cassel, J.-C., & Jeltsch, H. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00241-a · Cited by 256
Lasky‐Su, J. A., Faraone, S. V., Glatt, S. J., & Tsuang, M. T. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30104 · Cited by 256
Sánchez, C., & Meier, E. (1997) · Psychopharmacology · doi:10.1007/s002130050181 · Cited by 255
Positron emission tomography imaging in depression: a neural systems perspective
Mayberg, H. S. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00104-7 · Cited by 255
Elevated plasma nitrate levels in depressive states
Suzuki, E., Yagi, G., Nakaki, T., Kanba, S., & Asai, M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00164-6 · Cited by 255
Millan, M. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.038 · Cited by 255
Self-citationThe histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders
Passani, M. B., Lin, J.-S., Hancock, A., Crochet, S., & Blandina, P. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.003 · Cited by 255
Chaki, S., Yoshikawa, R., Hirota, S., Shimazaki, T., Maeda, M., Kawashima, N., Yoshimizu, T., Yasuhara, A., Sakagami, K., Okuyama, S., et al. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.009 · Cited by 254
Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain
Narita, N., Hashimoto, K., Tomitaka, S.-I., & Minabe, Y. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00254-3 · Cited by 254
Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei
Adell, A., Celada, P., Abellán, M. T., & Artigas, F. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00182-0 · Cited by 254
Bhagwagar, Z., Rabiner, E. A., Sargent, P. A., Grasby, P. M., & Cowen, P. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001401 · Cited by 254
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
Schmidt, P. J., Daly, R. C., Bloch, M., Smith, M. J., Danaceau, M. A., Simpson St. Clair, L., Murphy, J. H., Haq, N., & Rubinow, D. R. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.154 · Cited by 254
Chaouloff, F. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00008-1 · Cited by 253
Katz, M. M., Tekell, J. L., Bowden, C. L., Brannan, S., Houston, J. P., Berman, N., & Frazer, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300341 · Cited by 252
Homayoun, H., Stefani, M. R., Adams, B. W., Tamagan, G. D., & Moghaddam, B. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300417 · Cited by 252
Rickels, K., Pollack, M. H., Sheehan, D. V., & Haskins, J. T. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.968 · Cited by 252
Morilak, D. A., & Frazer, A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004080 · Cited by 252
Cryan, J. F., O'Leary, O. F., Jin, S.-H., Friedland, J. C., Ouyang, M., Hirsch, B. R., Page, M. E., Dalvi, A., Thomas, S. A., & Lucki, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401080101 · Cited by 252
Constitutive Activity and Inverse Agonists of G Protein-Coupled Receptors: a Current Perspective
Milligan, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1271 · Cited by 252
Altshuler, L. L., Bauer, M., Frye, M. A., Gitlin, M. J., Mintz, J., Szuba, M. P., Leight, K. L., & Whybrow, P. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1617 · Cited by 250
Steroids, neuroactive steroids and neurosteroids in psychopathology
Dubrovsky, B. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.001 · Cited by 250
Is there a delay in the antidepressant effect? A meta-analysis
Posternak, M. A., & Zimmerman, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0201 · Cited by 250
de Foubert, G., Carney, S. L., Robinson, C. S., Destexhe, E. J., Tomlinson, R., Hicks, C. A., Murray, T. K., Gaillard, J. P., Deville, C., Xhenseval, V., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.054 · Cited by 249
The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France
Bonierbale, M., Lançon, C., & Tignol, J. (2003) · Current Medical Research and Opinion · doi:10.1185/030079902125001461 · Cited by 249
Biogenic amine transporters: regulation in flux
Blakely, R. D., & Bauman, A. L. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00088-x · Cited by 249
Leysen, J. (2004) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007043482598 · Cited by 249
A Primitive Enantiornithine Bird and the Origin of Feathers
Zhang, F., & Zhou, Z. (2000) · Science · doi:10.1126/science.290.5498.1955 · Cited by 248
Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression
Ostroff, R. B., & Nelson, J. C. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0410 · Cited by 248
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults
Miller, G. E., Freedland, K. E., Carney, R. M., Stetler, C. A., & Banks, W. A. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(03)00057-6 · Cited by 248
Millan, M. J., Brocco, M., Gobert, A., & Dekeyne, A. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1962-z · Cited by 248
Self-citationEscitalopram versus citalopram: the surprising role of the R-enantiomer
S�nchez, C., B�ges�, K., Ebert, B., Reines, E., & Braestrup, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1865-z · Cited by 248
Coevolution of gene expression among interacting proteins
Fraser, H. B., Hirsh, A. E., Wall, D. P., & Eisen, M. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402591101 · Cited by 248
Sterling, J., Herzig, Y., Goren, T., Finkelstein, N., Lerner, D., Goldenberg, W., Miskolczi, I., Molnar, S., Rantal, F., Tamas, T., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020120c · Cited by 247
Absorption Classification of Oral Drugs Based on Molecular Surface Properties
Bergström, C. A. S., Strafford, M., Lazorova, L., Avdeef, A., Luthman, K., & Artursson, P. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020986i · Cited by 247
Melkersson, K., & Dahl, M.-L. (2004) · Drugs · doi:10.2165/00003495-200464070-00003 · Cited by 247
Rénéric, J.-P., & Lucki, I. (1998) · Psychopharmacology · doi:10.1007/s002130050555 · Cited by 247
Bagdy, G., Graf, M., Anheuer, Z. E., Modos, E. A., & Kantor, S. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002632 · Cited by 247
Mechanisms of action of PDE5 inhibition in erectile dysfunction
Corbin, J. D. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901205 · Cited by 246
Entsuah, A. R., Huang, H., & Thase, M. E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1106 · Cited by 245
Selective Substrates for Non-Neuronal Monoamine Transporters
Gründemann, D., Liebich, G., Kiefer, N., Köster, S., & Schömig, E. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.1 · Cited by 245
Daytime sleepiness and insomnia as correlates of depression.
D, M. F. M. (2004) · PubMed · Cited by 245
A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine
Carpenter, L. L., Yasmin, S., & Price, L. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01262-8 · Cited by 244
The pharmacology of putative early-onset antidepressant strategies
Blier, P. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00173-6 · Cited by 244
Young, A. H., Sahakian, B. J., Robbins, T. W., & Cowen, P. J. (1999) · Psychopharmacology · doi:10.1007/s002130051057 · Cited by 244
Neuropsychological function in nonpsychotic unipolar major depression.
Landrø, N. I., Stiles, T. C., & Sletvold, H. (2001) · PubMed · Cited by 243
The ESEMeD/MHEDEA 2000 investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00328.x · Cited by 242
Croft, H., Settle, E., Houser, T., Batey, S. R., Donahue, R. M. J., & Ascher, J. A. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88317-4 · Cited by 242
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
Paul, I. A., Nowak, G., Layer, R. T., Popik, P., & Skolnick, P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38715-x · Cited by 241
Apomorphine-induced penile erection and yawning: site of action in brain
Melis, M. R., Argiolas, A., & Gessa, G. L. (1987) · Brain Research · doi:10.1016/0006-8993(87)90272-1 · Cited by 240
Seidman, S. N., Roose, S. P., Menza, M. A., Shabsigh, R., & Rosen, R. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1623 · Cited by 240
The recombinant 5‐HT1A receptor: G protein coupling and signalling pathways
Raymond, J. R., Mukhin, Y. V., Gettys, T. W., & Garnovskaya, M. N. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702723 · Cited by 239
Hajszan, T., MacLusky, N. J., & Leranth, C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03968.x · Cited by 239
Gould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001518 · Cited by 238
An evaluation of the abuse potential of modafinil using methylphenidate as a reference
Jasinski, D. R. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400107 · Cited by 238
Criticality and disturbance in spatial ecological systems
PASCUAL, M., & GUICHARD, F. (2005) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2004.11.012 · Cited by 238
Dopamine D3 receptor antagonists as therapeutic agents
Joyce, J. N., & Millan, M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03491-4 · Cited by 237
Self-citationMonoamine depletion in psychiatric and healthy populations: review
Booij, L., Van der Does, A. J. W., & Riedel, W. J. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001423 · Cited by 237
Peretti, S., Judge, R., & Hindmarch, I. (2000) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2000.tb10944.x · Cited by 236
Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
Jacobsen, F. M. (1992) · PubMed · Cited by 236
(2003) · PubMed · Cited by 236
Bauman, A. L., Apparsundaram, S., Ramamoorthy, S., Wadzinski, B. E., Vaughan, R. A., & Blakely, R. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07571.2000 · Cited by 235
Oligomerization of serotonin transporter and its functional consequences
Kilic, F., & Rudnick, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3106 · Cited by 235
Sigma receptors: biology and therapeutic potential
Guitart, X., Codony, X., & Monroy, X. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1920-9 · Cited by 234
Liggett, S. B., Freedman, N. J., Schwinn, D. A., & Lefkowitz, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3665 · Cited by 234
Novel naphthalenic ligands with high affinity for the melatonin receptor
Yous, S., Andrieux, J., Howell, H. E., Morgan, P. J., Renard, P., Pfeiffer, B., Lesieur, D., & Guardiola-Lemaitre, B. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00086a018 · Cited by 234
Wells, K. B., & Sherbourne, C. D. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.897 · Cited by 234
Bonanno, G., Giambelli, R., Raiteri, L., Tiraboschi, E., Zappettini, S., Musazzi, L., Raiteri, M., Racagni, G., & Popoli, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5033-04.2005 · Cited by 234
Nitric oxide synthase inhibitors have antidepressant-like properties in mice
Harkin, A. J., Bruce, K. H., Craft, B., & Paul, I. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00191-0 · Cited by 233
Motor and cognitive aspects of motor retardation in depression
Caligiuri, M. P., & Ellwanger, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00068-3 · Cited by 233
Regulation of Nicotinic Acetylcholine Receptor Numbers and Function by Chronic Nicotine Exposure
Gentry, C., & Lukas, R. (2002) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007023339184 · Cited by 232
Kasper, S., & Olié, J. P. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00651-x · Cited by 232
Zhang, W. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00119-6 · Cited by 232
Bagley, J., & Moghaddam, B. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00435-6 · Cited by 231
Guscott, M., Bristow, L. J., Hadingham, K., Rosahl, T. W., Beer, M. S., Stanton, J. A., Bromidge, F., Owens, A. P., Huscroft, I., Myers, J., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.015 · Cited by 231
Prickaerts, J., van Staveren, W. C. G., Şik, A., Markerink-van Ittersum, M., Niewöhner, U., van der Staay, F. J., Blokland, A., & de Vente, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00199-9 · Cited by 231
Stress, Corticotropin‐releasing Factor, and Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07876.x · Cited by 231
Millan, M. J., Lejeune, F., & Gobert, A. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400202 · Cited by 231
Self-citationPuig, M. V. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh104 · Cited by 231
Grunhaus, L., Schreiber, S., Dolberg, O. T., Polak, D., & Dannon, P. N. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01499-3 · Cited by 230
Atypical neuroleptics stimulate neurogenesis in adult rat brain
Wakade, C. G., Mahadik, S. P., Waller, J. L., & Chiu, F. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10281 · Cited by 230
Svenningsson, P., Tzavara, E. T., Witkin, J. M., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052712799 · Cited by 230
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.